3507 results for «2037»
3507 results
Calcified un-dilatable lesions in ACS: what should I do?
22 May 2025 – From EuroPCR 2025
Address the challenges of severely calcified undilatable lesions during acute coronary syndrome PCI. This session reviews the impact of coronary calcification on PCI strategy, highlights pitfalls in lesion preparation, and presents detailed case studies demonstrating effective treatment approaches.
Imaging essentials in mitral regurgitation
17 Nov 2019 – From PCR London Valves 2019
Consult this session focusing on imaging in mitral regurgitation to gain insight into the importance of echocardiography in transcatheter mitral procedures to assess mitral valve morphology, regurgitation severity and risks for complications and to guide access, device positioning and post-deployment hemodynamics.
Introduction to the PCR London Valves 2019 Mitral and Tricuspid track - The key questions in mitral and tricuspid valve interventions: where are we in 2019?
18 Nov 2019 – From PCR London Valves 2019
Consult this session to appreciate the critical importance of the Heart Team in identifying the optimal treatment strategy for patients with mitral and tricuspid valve disease, and to learn more about the challenges of transcatheter mitral and tricuspid valve interventions and the complexities associated with patient and device...
Mitral regurgitation: a comprehensive patient-based approach
18 Nov 2019 – From PCR London Valves 2019
Consult this session to learn more about the pathophysiology of mitral regurgitation, and discover its implications for device design, selection and durability, which imaging modality is the most relevant to clinical decision-making, and how Heart Team working can provide the best treatment option for complex patients.
Introduction to the PCR London Valves 2019 Aortic Track - The key questions in TAVI: where are we in 2019?
18 Nov 2019 – From PCR London Valves 2019
Consult this session on the key questions in TAVI to learn more about the challenges, the latest evidence addressing the unresolved questions (durability, concomitant CAD, reaccess, asymptomatic AS...) and how to apply this information in your daily clinical practice.
Case-based learning for the Heart Valve Team: bioprosthetic valve thrombosis
18 Nov 2019 – From PCR London Valves 2019
Consult this session on bioprosthetic valve thrombosis to learn more about its detection and management, with a focus on the key role of imaging in the follow-up of patients, and discover how to identify patients at high risk of thrombosis or bleeding and their optimal management.
PCR London Valves Opening Ceremony
18 Nov 2019 – From PCR London Valves 2019
Consult this session on PCR London Valves, a patient-oriented course for all of the heart valve team, to discover the 2019 Opening Ceremony, led by Jean Fajadet: learn all about the course program, and how it will enhance your clinical practice.
TAVI: clinical outcomes with new devices and delivery systems
18 Nov 2019 – From PCR London Valves 2019
Consult this session on TAVI to learn more about the clinical outcomes with new devices and delivery systems, such as the self-expandable Portico valve, the Portico IDE FlexNav delivery system, the SAPIEN 3 Ultra system, and more!
Long-term clinical outcomes after SAVR and TAVI
19 Nov 2019 – From PCR London Valves 2019
Consult this session to learn all about the long-term clinical outcomes after SAVR and TAVI, thanks to a variety of studies and registries: BIVOLUT-X, STS/ACC TVT, and more!
New perspectives – Treatment of secondary mitral regurgitation in patients with heart failure
18 Nov 2019 – From PCR London Valves 2019
Consult this session on the treatment of secondary mitral regurgitation in patients with heart failure to learn more about how to implant the Carillon Mitral Contour System, and what is the impact of cinching the mitral apparatus on regurgitant volume and left ventricular remodeling.
Controversy - Challenges for the Heart Team II - Mitral regurgitation and heart failure - Where two worlds meet
19 Nov 2019 – From PCR London Valves 2019
Consult this session on mitral regurgitation and heart failure to hear the latest thinking concerning the optimal management of patients suffering from these diseases, and discover the implications of recent trials for your clinical practice, such as COAPT, MITRA-FR, and more!
TAVI: management of unusual complications
19 Nov 2019 – From PCR London Valves 2019
Consult this session to learn more about how to manage the following unusual TAVI complications: wire entrapment in hypertrabecular left ventricle after aortic valve release, iatrogenic VSD after TAVI in a patient with bicuspid severe aortic stenosis, ruptured pseudoaneurysm of the mitral-aortic intervalvular fibrosa, unsuccessful TAVI in...
Improving patient access and clinical outcomes in the treatment of aortic stenosis - The Edwards Benchmark Program
18 Nov 2019 – From PCR London Valves 2019
Consult this session to learn more about the current and future constraints on aortic stenosis treatment in Europe, and gain insight into the Edwards Benchmark Program, aiming to optimize patient outcomes, care pathway and efficiency.
Heart Team 2.0 in action: how to manage complex TAVI procedures
18 Nov 2019 – From PCR London Valves 2019
Consult this session to learn how to plan a successful TAVI procedure for your patients with challenging anatomy and high-risk clinical characteristics, such as: with a bicuspid aortic valve and associated aortopathy, with severe LVOT calcification, with a high risk of left main coronary occlusion, and more!
Mitral and tricuspid transcatheter valves therapies: time to innovate!
Consult this session on mitral and tricuspid transcatheter valves therapies to learn all about the recent innovations and clinical evidences, and discover the Tendyne Clinical Program, a new transcatheter treatment option that eliminates mitral regurgitation.
Will PARTNER-3 and Evolut low-risk trials change my practice?
18 Nov 2019 – From PCR London Valves 2019
Consult this session to learn all about PARTNER-3 and Evolut trials, and gain an in-depth understanding of these trials comparing TAVI and SAVR in patients at low surgical risk, while appreciating their limitations and key remaining questions.
PCR London Valves Closing Ceremony
19 Nov 2019 – From PCR London Valves 2019
Consult this session to discover PCR London Valves 2019 Closing Ceremony, which gathered over 3000 participants, and learn all about the key moments and what makes this course a wonderful opportunity to enhance your knowledge on transcatheter therapies for valvular heart disease.
PCR London Valves 2019 case submissions: Top 3 cases
18 Nov 2019 – From PCR London Valves 2019
Discover three compelling cases on double valve-in-valve, ring fracture and BASILICA, a complex mitral intervention with complications, and the treatment of ascending aorta, aortic root and aortic valve at the same time.
TAVI in patients with associated disease of the aorta
19 Nov 2019 – From PCR London Valves 2019
Consult this session on TAVI in patients with associated disease of the aorta to discover various challenging clinical cases: transapical revalving in type B aortic dissection, abdominal aortic rupture treatment during TAVI, double TEVAR for aortic aneurysm and type A aortic dissection, and more!
Advances in transcatheter mitral and tricuspid repair
18 Nov 2019 – From PCR London Valves 2019
Consult this session to learn about the recent advances in transcatheter mitral and tricuspid repair and their impact on your clinical practice, thanks to various registries and studies, such as EREMMI, GRASP-IT, LVEF, CLASP, and more!
